Rory Kelleher is the global business development lead for healthcare and life sciences at NVIDIA. He’s responsible for building strategic engagements in pharma, healthcare research, and insurance markets to transform their businesses through deep learning and GPU-accelerated applications. In his spare time, he enjoys the outdoors, experiencing new cultures, and various athletic activities.
“This year, every industry will become a technology industry,” NVIDIA founder and CEO Jensen Huang told attendees Wednesday during the annual J.P. Morgan Healthcare Conference. “You can now recognize and… Read Article
Generative AI is transforming drug research and development, enabling new discoveries faster than ever — and Amgen, one of the world’s leading biotechnology companies, is tapping the technology to power… Read Article
Genentech, a member of the Roche Group, is pioneering the use of generative AI to discover and develop new therapeutics and deliver treatments to patients more efficiently. A new collaboration… Read Article
Mitsui & Co., Ltd., one of Japan’s largest business conglomerates, is collaborating with NVIDIA on Tokyo-1 — an initiative to supercharge the nation’s pharmaceutical leaders with technology, including high-resolution molecular… Read Article
Scientists and healthcare researchers — once limited by the number of samples that could be studied in a wet lab, or the quality of microscopes to peer into cells —… Read Article
Academic medical centers worldwide are building new AI tools to battle COVID-19 — including at Mass General, where one center is adopting NVIDIA DGX A100 AI systems to accelerate its… Read Article